XOPENEX HFA

Lupin Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Jan 1, 2024
Approval ID: 70a35706-d7a8-4a48-98c6-1cab1c42fe8d
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use XOPENEX HFA safely and effectively. See full prescribing information for XOPENEX HFA.XOPENEX HFA (levalbuterol tartrate) inhalation aerosol, for oral inhalation useInitial U.S. Approval: 1999

Quick Stats

Total Products1

Labelers2

Label Sections39

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.